Who may participate
People who take part in clinical trials are key to advancing medical research. This study is seeking healthy male or female volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:
- Females must use a highly-effective, non-hormonal method of birth control
- Able and willing to abstain from certain foods prior to and throughout study participation
- Willing to take a study drug
- Able to meet all study visit requirements
There are other requirements for participation in this study. The study staff will explain these to you during the screening process
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
If this study may be a fit for you, you will be invited to attend a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing begins.
You will stay for 13 consecutive nights at our facility. During your stay you will receive one oral dose of caffeine, multiple once-daily oral doses of the study drug, and one dose of both caffeine and the study drug together.
Throughout the study, staff will monitor your health status, ask how you are feeling, and collect other data, such as the levels of caffeine and the study drug in your blood. A follow-up call will occur about 28-35 days after your last dose.
Interested in participating?
Complete and submit this form, and a Pfizer Clinical Research Unit (PCRU) representative will contact you.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in this clinical study, as well as other current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.